P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Looking for 8 startups to present their technology/products during the Startup Lightning Talks and Networking Exhibit of the 2023 MIT Corporate Innovation and Venturing Forum in NYC on June 7.
P&G is looking for partners and solutions that can support the automation of tanker truck & piston tanker connection for loading / unloading of chemical payloads, and are available to execute a pilot in the United States.
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference The Future of Cell & Gene Therapies
The Future of Industrial Cooling Maher Damak, Co-Founder & CEO, Infinite Cooling Infinite Cooling: https://www.infinite-cooling.com/
Cooling towers are ubiquitous in industrial and commercial settings. They are critical pieces of equipment but also major sources of energy and water consumption. They are used across a wide range of applications, including power generation, manufacturing, chemical processing, and HVAC systems for large buildings and data centers.
At Infinite Cooling, we begin with TowerPulse, our advanced sensors and software package that leverages physics-informed machine learning to optimize cooling tower operations. TowerPulse enables real-time monitoring and predictive maintenance, ensuring optimal performance, reducing energy consumption, and minimizing operational downtime.
Building on this, our WaterPanel technology uses electrostatic fields to captures pure, demineralized water directly from cooling tower plumes. This innovative solution provides an alternative demineralized water source while eliminating visible plumes, helping facilities conserve water, lower costs, and reduce environmental impact. Together, these technologies address key sustainability and efficiency challenges in industrial cooling.
Synthetic Biology Workshop 2017 - Panel Discussion
Looking for 10 Startups to present their technology at R&D during Lightning Talks and Lunch Exhibit - Nov 18 @Boston Marriott Cambridge.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.